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Abstract
Percutaneous left atrial appendage (LAA) occlusion is now a valid alternative to long-
term oral anticoagulation in patients with non-valvular atrial fibrillation at high thrombo-
embolism risk, especially for patients who are considered ineligible for anticoagulation. 
The most frequently used occluders worldwide include the WATCHAMN (Boston 
Scientific, Natick, MA, USA) and the Amplatzer Cardiac Plug or Amulet (St. Jude 
Medical/Abbott, St Paul, MN, USA) devices. Multimodality imaging is key in the 
understanding of 3D aspects of the LAA and surrounding structures anatomy. 
Imaging is essential for procedural planning, during each step of the procedure and 
for device surveillance after implantation. Multimodality imaging, including 2D/3D 
echocardiography, fluoroscopy, and cardiac computed tomography can increase the 
safety and efficacy of the procedure.
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Left atrial appendage (LAA) occlusion is increasingly rec-
ognized as a valid non-pharmacologic therapy for stroke 
prevention in high-risk patients with non-valvular atrial 
fibrillation (AF), especially in cases where long-term oral 
anticoagulation (OAC) therapy is contraindicated. Two 
randomized-controlled trials, the PROTECT AF and PRE-
VAIL studies, have shown the safety and efficacy of this pro-
cedure in patients randomized to either LAA closure with 
the WATCHMAN device (Boston Scientific, Natick, MA, 
USA) or warfarin therapy [1, 2]. Two large registries in 
patients who were mostly contra-indicated or deemed un-
suitable to long-term anticoagulation and treated with the 
Amplatzer Cardiac Plug (ACP) (St. Jude Medical/Abbott, 
St Paul, MN, USA) (ACP multicenter registry) [3] or the 
WATCHMAN (Ewolution registry) [4] have confirmed 
safety and efficacy of this procedure in this population. Cur-
rently, the European Society of Cardiology (ESC) guide-
lines for the management of AF recommend that LAA clo-
sure may be considered in patients with high-risk of stroke 
and contraindications to long-term OAC (class IIb, level of 
evidence B) [5]. The 2014 American (ACC/AHA/HRS) 
guidelines on management of AF have not made any recom-
mendation on this procedure [6]. Food Drug Administra-
tion approval in the USA for the WATCHMAN device was 
obtained in March 2015 for patients with non-valvular AF 
and high-risk of stroke who have an appropriate rationale to 
seek a non-pharmacologic alternative to warfarin.
Imaging is a key part of LAA occlusion as it portends pa-
tient selection, device selection, procedural guidance and 
post-implantation surveillance. Different imaging mo-
dalities are currently used for each of these steps, as mul-
timodality imaging in this procedure has the potential to 
improve procedure safety and efficacy. Close collaboration 
and excellent communication between the operator and the 
imaging specialist are essential. The implanting team has to 
understand the various steps of the procedure, its complexi-
ty and 3D anatomy of the LAA and surrounding structures. 
This review will focus on the role of imaging in LAA closure 
with the most commonly used devices, the WATCHMAN 
and the ACP/Amulet. After explaining the role of imaging 
in the different steps of the procedure, specific aspects will 
be developed with emphasis on transoesophageal echocar-
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Characteristics of the ACP/Amulet and Watchman 
Devices
The ACP or Amulet (second generation ACP) devices are 
self-expanding nitinol devices made of a distal lobe, de-
signed to anchor the device in the LAA, connected by a 
short mobile waist to a proximal disc, covered by polyes-
ter patches and intended to seal the LAA orifice [7]. ACP 
sizing depends on the widest landing zone. It is recom-
mended to oversize the device by 2-4 mm for the ACP and 
3-6 mm for the Amulet from the widest measured landing 
zone. The WATCHMAN device is a self-expanding nitinol 
frame structure with fixation barbs and a permeable poly-
ester fabric cover [8]. WATCHMAN sizing is based on the 
maximum LAA diameter, which should be 17 to 31 mm to 
accommodate available devices. A 8-20% compression ratio 
based on the widest measurement is recommended by the 
manufacturer, while most implanters will aim for the higher 
compression range (close to 20%). Given that the WATCH-
MAN is almost as long as it is wide, the depth of the distal 
(implant) lobe has to be as deep as the diameter of the de-
vice chosen.
ROLe Of IMAgINg IN PROCeDUraL STePS
Pre-Procedural Planning
Baseline assessment of the LAA days to weeks prior to the 
procedure is a recommended standard of practice for percuta-
neous LAA occlusion. This evaluation will gather information 
about presence of thrombus, LAA morphology and size, other 
cardiac structures and will exclude contra-indications for LAA 
closure. TOE is the preferred modality but alternative (in case 
of contraindications to TOE) or complementary imaging by 
CCTA is increasingly performed [9, 10]. Many authors judge 
the presence of thrombus as an absolute contra-indication 
for LAA closure. If thrombus is detected during the pre-pro-
cedural work-up, anticoagulation should be initiated or inten-
sified for at least 3-4 weeks with repeated imaging to confirm 
thrombus resolution before proceeding with LAA occlusion 
[6]. LAA morphology and dimensions can be identified in the 
pre-procedural study. The orifice diameter, the landing zone 
diameter and the depth of the LAA can be measured. This will 
orient device selection and ensure that LAA closure is feasible. 
figure 1: Step-by-step 2D/3D Transoesophageal (TOE) Guidance for Left atrial Appendage (LAA) Occlusion with an Amulet Device.
A: Step 1: The transseptal needle is pulled down with imaging guidance in the bicaval view (from superior to inferior positioning).
B: Step 2: Bicaval and short-axis views allowing visualization of the needle tenting on the fossa ovalis. The goal is to puncture in the infero-posterior region of the 
fosa ovalis. The use of X-plane or Bi-plane view is recommended.
C: Step 3: Gentle advancement of the guide through the interatrial septum (IAS) is tracked in X-plane or Bi-plane view.
D: Step 4: The pigtail catheter is advanced inside the LAA. Real-time 3D TOE with zoom is the preferred modality for guidance.
E: Step 5: Positioning and deployment of the device lobe inside the LAA is followed on 3D TOE.
F: Step 6: Real-time 3D TOE with zoom shows the deployment of the disc at the level of the LAA orifice. The saddling of the disc in the LAA orifice can be imaged 
with 3D zoom mode.
G: Step 7: Position of the device lobe inside the LAA in relationship with the left circumflex (LCx) artery is assessed. 60 to 90⁰ views on 2D will image the LCx 
artery.
H: Step 8: A tug test is performed to test device stability inside the LAA.
I and J: Step 9: Once the final position is considered appropriate, residual peri-device leaks are looked for with 2D color flow mode with adapted velocities at 45⁰, 
60⁰, 90⁰ and 135⁰. Bi-plane views with color-flow can also be used (panel J).
K: Step 10: On 3D zoom, the anatomic relationship between the disc of the device, the left pulmonary veins and the mitral valve are evaluated.
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The orientation of the LAA may help operators in selecting the 
type of access sheath. Characteristics of the inter-atrial septum 
(IAS) will be assessed as some features may be associated with 
a difficult transseptal puncture (TSP). For instance, the pres-
ence of thick or aneurysmal IAS will be evaluated.
Procedural guidance
Interventions are performed with fluoroscopy while TOE 
allows guidance during the different procedural steps (Fi 1). 
TOE guidance during TSP is an important step as a puncture 
in the optimal infero-posterior region of the fossa ovalis may 
greatly facilitate further steps of LAA occlusion. Live TOE 
guidance improves safety of the TSP and increases the like-
lihood of an optimal TSP location. Wire and pigtail catheter 
position can also be identified more easily with TOE and pro-
cedure time may be shortened with guidance. Sheath position-
ing is visualized with TOE and fluoroscopy, ensuring a good 
co-axial alignment and access to the culprit (or implant) lobe. 
LAA morphology and sizing will be estimated by both imaging 
in several incidences. It is important to ensure that adequate 
filling pressure is present within the LA cavity to avoid under-
estimation of the dimension of the LAA landing zone [11]. 
Successful implantation is evaluated based on pre-specified cri-
teria; different for each device and ensuring complete seal and 
good stability. The presence of complications is best assessed 
by TOE (e.g., pericardial effusion, mitral valve impingement, 
left pulmonary vein occlusion). 
Post-Procedural Device Surveillance
We routinely perform Chest X-ray and transthoracic echocardi-
ography (TTE) before patient discharge to ensure the absence 
of device embolization and pericardial effusion. Post-procedur-
al TOE and/or CCTA can be performed 1-3 months post-im-
plantation. Imaging will assess presence of device-associated 
thrombus (DAT) and peri-device leaks and will rule out any 
complication (e.g., device embolization, pericardial effusion). 
Results of post-implantation imaging are used in many centers 
to modify antithrombotic treatment (switch form warfarin to 
dual antiplatelet therapy (DAPT) or from DAPT to aspirin 
alone). Further imaging is indicated in case of clinical events 
potentially related to device complication (Table 1).
ROLe Of IMAgINg IN SPeCIfIC SITUATIONS 
OR INDICATIONS
Sizing
Correct sizing is of utmost importance for the optimization 
of the efficacy and safety of the procedure. Proper sizing will 
allow complete closure of the LAA with good device stabili-
ty. Undersizing may increase peri-device leakage and increases 
the risk of device instability leading to dislodgement and em-
bolization. Oversizing increases the risk of pericardial effusion, 
cardiac perforation and cardiac tamponade, long-term erosion 
and device instability. Thus, precise knowledge of LAA orifice 
dimensions is crucial for the selection of the occluder size. The 
measurements should be performed when the LAA size is the 
largest, at the end of the ventricular systole and under normal 
LA filling conditions. Performing multiple measurements in 
different views and ideally with multiple imaging modalities is 
necessary in order to select the proper device type and appro-
priate device size for LAA closure. Depending on the device 
used, specific measurements will be performed. The short-axis 
view enables measurements of maximal LAA diameters while 
the long-axis view allows measurement of the LAA depth. 
With the probe in mid-oesophageal position, TOE imaging 
planes from 0-135° are obtained to perform measurements. 3D 
TOE may also be useful to find maximal and mean diameters. 
On CCTA, 3D multiplanar reconstruction (MPR) is typical-
ly used. Given the orientation of LAA, standard orthogonal 
views are indeed inadequate. 2D oblique measurements are 
used after manipulation of cross-sectional orthogonal views. 
After identification of the LAA orifice in a plane showing the 
circumflex artery and the pulmonary vein ridge, an orthogonal 
plane is obtained to ensure good co-axial alignment. The or-
thogonal “end-on” view allows measurements of LAA dimen-
sions at selected area of interest (Fi 2).
Table 1: Role of Imaging Modalities in Left Atrial Appendage Occlusion
evaluation fluoroscopy TOe ICe CCTA
Pre-procedural planning
Absence of thrombus in the LAA NA ++ NA ++
LAA morphology, orientation and size (length and diameters) NA ++ NA ++
Inter-atrial septum assessment NA ++ NA +
Per-procedural guidance
Absence of thrombus in the LAA - ++ ++ NA
Transseptal puncture + ++ ++ NA
Wires, catheters and sheath positioning ++ ++ + NA
Implantation success + ++ ++ NA
Peri-device leak - ++ ++ NA
Pericardial effusion - ++ ++ NA
Interaction of the device with other cardiac structures - ++ ++ NA
embolization ++ + + NA
Post-procedural device surveillance
Implantation success NA ++ NA ++
Peri-device leaks NA ++ NA ++
Device-associated thrombosis NA ++ NA ++
embolization NA + NA ++
Pericardial effusion NA ++ NA +
++: very useful; +: useful; -: inappropriate; NA: not applicable
Abbreviations: LAA: left atrial appendage; ICE: intracardiac echocardiography; TOE: transoesophageal echocardiography
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figure 2: Cardiac Computed Tomography Evaluation of a Patient 
Before Left atrial Appendage (LAA) Closure with a WATCHMAN 
Device.
A: Multiplanar reconstruction is required for analysis as axial views 
are inadequate for assessing LAA dimensions given the shape and 
orientation of LAA. Measurements are made during the phase that 
corresponds best to maximal LAA end-diastolic filling (LV end-sys-
tolic filling). In multiplanar reformat (MPR) images, planes are 
aligned to the direction of the main lobe of the LAA. The orthogo-
nal plane giving the LAA cross-section is moved to the level of the 
proximal left circumflex (LCx) artery.
B: Orthogonal (axial) cross-section (“end-on” view). Measure-
ments of the maximal and minimal diameters, the area and perime-
ter of the LAA landing zone can be obtained.
C: The maximal length or depth of the LAA is measured from the 
landing zone to the distal tip of the main lobe (implant lobe) of the 
LAA in the longitudinal view (use largest value in coronal or sagittal 
view).
D: Volume rendered three-dimensional image obtained by cardiac 
computed tomography of the LAA showing a Windsock shape.
Perimeter-derived diameter is the most reproducible pa-
rameter for sizing an LAA occluder. It provides mean and 
maximum diameters of the landing zone and may improve 
correct device selection, resulting in less over- or undersizing 
[12-14].
For the ACP/Amulet, the size of the device is mostly based 
on the landing zone diameter, where the lobe will be an-
chored. The “anatomical” ostium is the plane that joins the 
left superior pulmonary vein rim (the ligament of Marshall) 
superiorly with the inferior junction of LA/LAA at the level 
of the left circumflex artery. The landing zone can be found 
10 mm (for ACP) and 12 mm (for Amulet) below this seg-
ment, perpendicular to the major axis of the LAA, usually at 
the junction between the neck and the body of the LAA. The 
depth of the appendage is measured from the landing zone to 
the most distal tip of the main lobe of the appendage (Fig 3).
For the WATCHMAN device, the LAA anatomical orifice 
diameter is measured on TOE at 0°, 45°, 90° and 135°. The 
“effective” LAA orifice is defined as the plane connecting the 
pulmonary vein ridge superiorly (1-2cm within the left up-
per superior pulmonary vein ridge) to the inferior junction of 
the LA and the LAA at the level of the circumflex artery. The 
widest dimension should be used for sizing. Maximal length 
or depth of LAA is defined as the linear distance from the 
center of the landing zone to the distal tip of the main lobe of 
the appendage (Fig 4).
figure 3: TOE evaluation of a patient before left atrial appendage 
(LAA) closure by the Amulet device. Images are acquired in the 
mid-oesophageal view focused on the LAA at 0⁰, at 45⁰ at 90⁰ and 
at 125-135⁰. Measurements are performed in a frame that gives the 
largest LAA, usually in end-systole. The orifice of the LAA is mea-
sured in each of these views. The landing zone (the part of the LAA 
in which the lobe of the Amulet device will be fixed) is measured in 
each of these views at 10-12 mm from the LAA orifice. The depth is 
measured in the main lobe of the LAA.
figure 4: TOE images with measurements of the landing zone for 
left atrial appendage (LAA) closure with the WATCHMAN device 
at 0°, 45°, 90° and 135° views.
The shape of the LAA ostium is typically elliptical; other 
shapes have been less frequently described [13, 15]. Mark-
edly oval-shaped orifices or landing zones are associated 
with a significant difference between maximal and minimal 
diameters, which can be confounding and may lead to over- 
or under-sizing. Manufacturers’ recommendations for siz-
ing are based on maximal diameter on TOE. The elliptical 
shape of LAA short-axis has led to the development of more 
flexible devices (last generation devices), allowing for more 
successful occlusion. The LAA usable depth is measured in 
the long-axis view from the LAA orifice to the LAA apex. 
On TOE, the angle of choice depends on LAA orientation. 
Angles of 0°, 45° or 90° are typically used. In case of more 
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laterally orientated LAA, angle of 90° or more are necessary. 
On CCTA, the depth is best assessed on 3D MPR. The re-
quired depth is different between devices: ACP/Amulet de-
vices need 10-12 mm to accommodate the lobe, WATCH-
MAN requires an equivalent depth as the diameter of the 
device.
In a study by Saw et al., fluoroscopy, 2D TOE and CCTA 
showed good correlations for LAA measurements. CT pro-
vided the largest measurements, followed by TOE and fluo-
roscopy [16]. In another study, LAA dimensions measured 
by CCTA correlated with the diameters obtained with fluo-
roscopy and intracardiac echocardiography (ICE), but they 
were slightly larger than the others [17]. A particular value 
of CCTA may be the detection and subsequent avoidance 
of gross sizing error by 2D TOE that occurred in a small 
proportion of cases (3.4%) in a single-center registry [18]. 
In most studies, CCTA most often predicts the appropriate 
device size [10, 17, 19]. The use of real time 3D TOE for 
the visualization and quantitative analysis of LAA param-
eters is more frequent and has several advantages. RT3D-
TEE allows better spatial visualisation of the LAA and more 
comprehensive evaluation of the device and surrounding 
structures during the procedure. The use of MPR mode in 
3D TOE allows correct identification and direct planimet-
ric measurement of the LAA orifice area (Fig 5).
The measurements correlate well with those obtained with 
cardiac CT and are associated with a lower observer vari-
ability and higher accuracy and reliability than 2D TOE. 
Indeed, 2D TOE tends to significantly underestimate the 
maximal LAA orifice diameter compared to 3D TOE. There 
is a closer correlation between 3D TOE measurements and 
LAA closure device size than 2D TOE or angiographic 
measurements. After implantation, the device can be vi-
sualized more completely with 3D TOE [14, 20-23]. LAA 
is thought to have several functions, including acting as a 
reservoir during left ventricular systole. As such, LAA vol-
ume and sizes may vary with pressure and volume loading 
conditions. Typically, a minimal left atrial pressure of 10-15 
mmHg is mandatory before final device sizing assessment. 
Intraprocedural volume loading with saline, aiming for a LA 
pressure >12 mmHg, showed an increase in LAA dimen-
sions in a small study [11].
Morphology and Orientation
The morphology of the LAA is extremely complex and het-
erogeneous. Individual LAA morphology is unique and 
may sometimes be referred to as a fingerprint. In more than 
two-thirds of the cases, LAA is composed of 2 or more lobes 
that may be located in different planes [24]. Early TOE ana-
tomical studies described numerous shapes of LAA: narrow, 
tubular and hooked structure [25]. Currently used classi-
fication of LAA morphology is based on the general shape 
of the LAA. The four classical shapes are windsock (single 
dominant lobe without obvious bend), chicken wing (obvi-
ous bend in the body of the LAA), cactus (dominant central 
lobe with multiple secondary lobes) and cauliflower (short 
body with numerous secondary lobes and more complex in-
ternal characteristics) [13]. Different studies have evaluated 
a correlation between the thromboembolism risk and LAA 
morphological or structural features. LAA morphology has 
been shown to be a significant determinant of LAA flow
figure 5: Step-by-step Real-time 3D TOE Evaluation for Left Atrial Append-
age (LAA) Closure Device Sizing.
Step 1: In the frame with the largest LAA dimensions (usually end-systole), 
the first plane is positioned to transect the left circumflex (LCx) artery (this 
plane cuts the LAA showing the inferior and the superior walls of the LAA) 
and aligned to be parallel to the long-axis of the LAA.
Step 2: The second orthogonal plane is aligned with the long-axis of the LAA 
(Panel A).
Step 3: The third plane, the axial plane (green), is moved to be at the intersec-
tion of the LCx artery and the ridge of the left upper pulmonary vein. At this 
point the diameters of the LAA orifice can be measured (Panel B).
Step 4: The axial plane (green) is moved into the LAA to the estimated landing 
zone. The diameters of the landing zone can be measured in this view. (Panel 
C). For the WATCHMAN, this plane should transect the LCx artery and a 
point lower than the ridge but above the trabeculated parts of the LAA. For 
the Amulet-ACP, this plane is moved 10-12 mm into the LAA from the LAA 
ostium.
In our example, the measurements were made before Amulet implantation. 
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velocity, suggesting an underlying mechanism for the as-
sociation between LAA morphology and embolic events 
[26]. Patients with chicken wing LAA morphology were 
shown to less likely develop an embolic event even after 
controlling for comorbidities and CHADS2 score [27]. 
This was confirmed in a recent meta-analysis [28]. Large 
LAA neck diameter and LAA depth as well as extensive 
LAA trabeculations may also be predictors of thromboem-
bolic events [29].
Accurate assessment of the anatomic LAA characteristics 
is crucial before an LAA occlusion procedure as variations 
in LAA anatomy may impact device selection and proce-
dure strategy. Understanding LAA morphology can help 
anticipating the complexity of the procedure and the need 
for the use of some unusual techniques. For example, the 
presence of a chicken wing morphology with an early and 
severe bend constitutes one of the most difficult anatom-
ical settings for LAA occlusion. A particular implanting 
strategy has been described with the ACP-Amulet device 
and consists of deploying the distal lobe of the device in-
side the chicken-wing bend (‘Sandwich’ technique) [30]. 
However, in some very complex chicken wing configura-
tion or in case of very shallow LAA, the anatomy may be 
judged as inappropriate for LAA closure. Determination 
of LAA orientation also has procedural implications. Most 
LAA are orientated superior-anteriorly. For this reason, 
most LAA occlusion procedures are performed with the so 
called double-curve sheaths (double-curve access sheath 
for WATCHMAN, Boston Scientific; TV45x45 for ACP/
Amulet, Saint-Jude Medical/Abbott). In cases of LAA ori-
ented infero-posteriorly, a single-curve may be preferred 
[13].
Images obtained by volume rendered (VR) 3D CCTA can 
also be useful to plan the procedure. With manipulation of 
VR images, it is possible to determine the best correspond-
ing fluoroscopic views to guide LAA occlusion during the 
procedure. The choice of the fluoroscopic views during 
the procedure relies on the LAA anatomy and on the de-
vice selected for the occlusion. The right anterior oblique 
(RAO) view with cranial projection (RAO 20-30°, cranial 
20-30°) identifies the left lateral ridge and shows the ori-
fice and proximal segment of the LAA best, which is par-
ticularly useful for ACP/Amulet implantation. On TOE, 
this view corresponds usually to the 45° view. The RAO 
view with caudal projection (RAO 20-30°, Caudal 20-30°), 
corresponding to the 135° view on TOE, can separate the 
possible anterior and posterior lobes and shows the body 
and distal segment of the LAA, which is useful for sheath 
placement in the distal lobe and for WATCHMAN deploy-
ment. As in transcatheter aortic valve implantation, CCTA 
can help planning the precise fluoroscopic implant angle.
Transseptal Puncture
Transseptal puncture is performed under fluoroscopy. Left 
anterior oblique view (30°) is preferred as the transsep-
tal needle is located perpendicular to the septum in this 
view when oriented at about 45° medially and posteriorly 
(clockwise, 4-6 o’clock orientation). After a first drop from 
the superior vena cava to the right atrium (RA) wall, the 
second drop confirms needle position in the fossa ovalis. 
TOE is useful for the transseptal puncture guidance as it 
allows targeting the infero-posterior region of the septum 
to perform the puncture (Figure 6).
figure 6: A: Bicaval view (90⁰) with the superior vena cava (SVC) 
on the right and inferior vena cava (IVC) on the left. The fossa ovalis 
(FO), the site of puncture, is imaged with its superior (close to the 
SVC) and inferior (close to the IVC) aspects. `
B: Short-axis view (45°) showing the aorta as a landmark. The FO is 
also visualized with its anterior (close to the aortic valve (Ao)) and 
posterior (close to the atrial roof) aspects.
C: Using bi-plane imaging with a 3D-TOE probe, the bicaval view 
shows the tenting of the FO (arrow) that results from impinging of 
the Brokenbrough needle into the FO.
D: The orthogonal plane (short-axis) is set through the tenting 
point to image the tenting on the FO from the antero-posterior as-
pect of the FO. The optimal area for puncture for LAA occlusion is 
the infero-posterior region of the interatrial septum.
Abbreviations: IAS: inter-atrial septum; LA: left atrium; RA: right 
atrium; SVC: superior vena cava.
Simultaneous TOE images demonstrate tenting of the in-
ter-atrial septum (IAS) due to pressure from the needle 
prior to the puncture. In the upper oesophageal position, 
the bicaval view (90-110°) assesses the height of the punc-
ture, while the short-axis view (30-60°) gives information 
about the antero-posterior position and allows puncture to 
be away from the aorta. As mentioned, ideal puncture loca-
tion lies in the infero-posterior region of the IAS as it facil-
itates coaxial orientation of the access sheath for accessing 
the LAA. TOE can identify features that may be associated 
with complex transseptal puncture (thick IAS, very en-
larged LA, aneurysmal IAS) and can therefore change pro-
cedural strategy (use of radiofrequency transseptal needle, 
increased transseptal needle curve…).
Successful Implantation
After implantation, evaluation of the success of the im-
plantation and the absence of complications are of utmost 
importance. TOE remains the gold-standard imaging mo-
dality for assessing the success of the implantation but 
fluoroscopy is complimentary. For the WATCHMAN, 
the PASS criterion should be achieved: Position (device 
is distal to or at the ostium of the LAA), Anchor (device 
is stable, fixation anchors engaged, tug test stability), Size 
(device is compressed 8-20% of original size), Seal (device 
spans ostium, all lobes of LAA are covered, peri-device leak 
<5mm). For the ACP/Amulet device, 5 criteria are used to 
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assess implantation adequacy: (1) tire-shape of the lobe, 
(2) separation of the lobe from the disc, 3) concavity of the 
disc, (4) axis of the lobe is perpendicular to the neck axis 
at landing zone, (5) lobe (at least 2 thirds) lies adequately 
within the circumflex artery. The disc should cover com-
pletely the anatomical orifice of the LAA. Gentle traction 
is applied to the disc and maintained for 30 seconds to con-
firm stability. The absence of significant peri-device leaks is 
assessed by TOE in all incidences (by color flow Doppler 
with Nyquist limit < 50cm.s-1) (Fig 7, panel A).
figure 7: Evaluation of Implantation Success and Complications 
After LAA Occlusion.
A: Perprocedural Color flow Doppler TOE imaging showing 
peri-device leak (arrow) after WATCHMAN implantation.
B: Contrast-enhanced CT images revealing an atrial-side device 
thrombus on a WATCHMAN device at the fabric insert (white ar-
row) and adjacent to the device (black arrow).
Reproduced with permission from Cardiac CT angiography for 
device surveillance after endovascular left atrial appendage clo-
sure; Saw et al.; European Heart Journal Cardiovascular Imaging; 
2015;16:1198-206. doi: 10.1093/ehjci/jev067. Oxford University 
Press.
C: Delayed embolization of an Amplatzer Cardiac Plug. TOE image 
showing entrapment of the device (arrow) in the anterior mitral ap-
paratus with flail leaflet (dotted arrow).
CCTA can also detect peri-device leaks and identify the 
underlying mechanism. Different aetiologies explain 
peri-device leaks. In WATCHMAN cases, leaks are mostly 
eccentric and secondary to an edge effect. For ACP/Amu-
let cases, higher proportion of off-axis lobes were found in 
cases of patent LAA [31, 32] and leaks were more frequent 
when lobe compression was ≤ 10% [33]. In the presence of 
peri-device leak ≥5mm, resuming or pursuing antithrom-
botic therapy or further intervention may be considered. 
However, the clinical impact of peri-device leak is un-
known with no clear relationship with adverse events [3, 
4, 34].
Thrombus
The rationale for LAA closure development was that 
around 90% of thrombi in the LA originated in the LAA 
in patients with non-valvular AF after evaluation by autop-
sy, TOE or operation [35]. In AF patients, LAA structure 
and function have several characteristics that make LAA a 
prothrombotic milieu favouring thrombus formation. The 
elements of the Virchow’s triad are found in this setting: 
blood stasis in this blind-ended pouch with trabeculations 
and electromechanical dysfunction [36, 37], endotheli-
al dysfunction (secondary to fibrosis and inflammation) 
[38]. and prothrombotic state (linked to the activation of 
coagulation cascade) [39, 40]. The presence of thrombus 
is usually considered as an absolute contra-indication for 
LAA closure, even though several cases of LAA occlusion 
with Amulet have been described [41, 42]. The standard 
of best practice recommends anticoagulation treatment 
for at least 3-4 weeks in case of detection of thrombus in 
the LAA [6]. Control imaging after this period to confirm 
thrombus resolution is recommended before procedure 
planning. Left atrial (LA) thrombus on TOE is recog-
nized as an echo dense mass, with smooth contours and 
synchronous movement with adjacent heart wall during 
heart cycle. TOE is considered the gold standard modal-
ity in detecting LA or LAA thrombi. In one intraoperative 
study, TOE was compared with direct visualization of LA 
contents at surgery and had a sensitivity and specificity of 
100% and 99%, respectively [43] 3D TOE can help dis-
criminate pectinate muscles from thrombus in cases with 
diagnostics doubts [44]. In case of uncertainty about the 
presence of a thrombus in the LAA, the use of ultrasound 
contrast can be helpful [45].
Studies with mutlidetector CT have reported good sen-
sitivity and specificity for CCTA for LAA thrombus de-
tection [46, 47]. Recent meta-analysis demonstrated that 
CT shows a good diagnostic accuracy in detecting LA/
LAA thrombus with high sensitivity and specificity [48, 
49]. This technique has a high negative predictive value for 
excluding LAA thrombus. Adaptation to CCTA protocols 
may improve LAA thrombus detection: delayed imaging 
(2-phase scan with delayed image acquisition at least 30 
seconds after contrast bolus), dual-enhanced scan (single 
scan after 2-bolus contrast), dual-energy source and prone 
position [50, 51]. When delayed imaging was performed, 
the diagnostic accuracy significantly improved across dif-
ferent studies [49]. Hence, CCTA, particularly when de-
layed imaging is performed, may be a reliable alternative 
for the detection of LA or LAA thrombi. Thrombus ap-
pears in this setting as round-shaped or oval filling defects 
(Fig 7, panel B).
The presence of DAT is assessed during post-procedural 
device surveillance. DAT is not rare, with an overall report-
ed rate of 3.9% in a recent review [52]. Diagnosis is most 
of the time performed during routine follow-up imaging, 
as most cases remain asymptomatic. Management consist 
mostly on short-term anticoagulation. Recently, Main et 
al. have proposed consensus echocardiographic diagnostic 
criteria for DAT diagnosis: echo density on the LA aspect 
of the device (1) not explained by imaging artefact; (2) 
inconsistency with normal healing/device incorporation; 
(3) visible in multiple TOE planes, (4) in contact with the 
LAA occluder device; and (5) exhibiting independent mo-
tion [53]. CCTA is also able to detect DAT or thrombus on 
the adjacent LA wall [32].
Complications
Device embolization is a well-known and feared compli-
cation of LAA closure with an average reported rate of 
less than 4% [54], and less than 1% in recent registries [3, 
4]. In a systematic review by Aminian et al., two-thirds of 
reported cases were acute, with 60% of those cases occur-
ring during the procedure. Most cases were asymptomatic 
[55]. Device embolization may be diagnosed by fluoros-
copy, chest X-ray, TTE, TOE or CCTA (Fig 7, panel C). 
Pericardial effusion incidence is decreasing with last gener-
ation of devices, standardization and better understanding 
of the procedure [2]. Pericardial effusion occurs mostly 
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during the procedure and is best diagnosed by echocardi-
ography. Pericardiocentesis is rarely necessary and can be 
echo-guided.
ALTeRNATIVe AND fUTURe IMAgINg MO­
DALITIeS
Intracardiac echocardiography (ICe)
With a successful ICE-guided LAA closure reported rate ≥ 
97%, ICE has proved to be a valid alternative imaging mo-
dality for LAA occlusion in experienced centers [56-59]. The 
main advantage of ICE utilization is that it avoids the need for 
general anaesthesia or deep sedation, which can be associated 
with additional complications (aspiration, delirium…), lead 
to longer procedure-time and to additional resource utiliza-
tion. Of note, a recent small study showed the feasibility of 
LAA closure using conscious sedation with TOE guidance 
[60] whereas another study described the use of an ICE-
TOE probe through the oesophageal route without general 
anaesthesia for the monitoring of ACP device implantation 
[61]. ICE currently lacks multiplanar capabilities and may 
provide suboptimal imaging of LAA, even though the abili-
ty to move the probe in different positions may compensate 
these shortcomings. Furthermore, location of the ICE probe 
within the LA cavity improves imaging of the LAA. The main 
disadvantages of ICE remain the additional cost and a signif-
icant learning curve. Several ICE catheters are commercially 
available including the AcuNav ultrasound catheter (Siemens 
Medical Solutions, USA, Inc., Mountain View, CA, USA) 
and the ViewFlex Xtra catheter (St. Jude Medical/Abbott). 
Both systems are available in 8-10 Fr size and can be steered 
in 4 directions (anterior, posterior, left, and right). They also 
have color flow and spectral Doppler capabilities. The cathe-
ters are inserted from the ipsilateral or contralateral femoral 
vein via large venous sheaths and advanced from the inferior 
vena cava to the working position. The ICE probe can be po-
sitioned in the RA, the coronary sinus [56], the pulmonary 
artery [62] or the LA via a single-transseptal approach or af-
ter a second transseptal puncture [57]. Once the desired po-
sition is achieved, the probe can be set in that position with 
a lock mechanism. ICE can provide detailed imaging of the 
LAA in multiple views with serial and real-time assessment 
of the procedures steps (Fig 8).
ICE guidance is able to achieve tasks typically performed by 
TOE: evaluation of the presence of thrombus [63]; transsep-
tal puncture guidance [64] measurement of LAA dimension 
for device sizing [17]; verification of the delivery sheath po-
sition; evaluation of device stability and peri-device leaks and 
continuous monitoring to detect procedural complications 
[56].
Integrated/Synchronized X-Ray and echocardiog-
raphy (fusion Imaging)
LAA occlusion procedures under fluoroscopic and echocar-
diographic guidance with image fusion technology have been 
described with good results [65]. The EchoNavigator ®-sys-
tem (Philips, Best, The Netherlands) is based on a fast and 
automated image based algorithm that localizes and tracks 
the TOE probe. Since the 3D dataset generated by the TOE 
probe has a known spatial relationship to the TOE probe, 
once the algorithm has recognized the TOE probe and its 
orientation, TOE images and X-Ray are co-registered and 
synchronized in real-time (Fig 9) [66].
figure 8:  Intracardiac Echocardiography (ICE) Guidance for Left Atrial 
Appendage (LAA) Occlusion. (A) Interatrial septal puncture (ICE probe 
in the right atrium); (B) visualization of the LAA and anatomy assessment 
(ICE probe in the left atrium); (C) device position assessment; (D) check 
for peri-device flow/leak with color Doppler flow imaging.
Abbreviations: LA: left atrium; RA: right atrium; W: WATCHMAN device.
Reproduced with permission from Intracardiac versus transesophageal echo-
cardiography for left atrial appendage occlusion with watchman; Frangieh et 
al.; Catheterization and Cardiovascular Interventions; 2016. doi: 10.1002/
ccd.26805. Wiley Periodicals, Inc.
figure 9:  Fusion Imaging Obtained with the EchoNavigator ®-system.
A: Fusion of the TOE image (left) with the fluoroscopy image (right) show-
ing the left atrial appendage (LAA) and surrounding structures. This imag-
ing modality allows identification of the position of the Coumadin ridge 
(yellow arrow) and facilitates positioning of the sheath in the LAA.
B: Fusion of the Color flow Doppler TOE image (left) with the fluoroscopy 
image showing the absence of obstruction to flow in the left upper pulmo-
nary vein (LUPV). The stability of the device (Amulet) is tested with appli-
cation of slight tension on the delivery cable (wiggle test).
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The system allows the simultaneous display of up to 3 differ-
ent echo views: 1) the C-arm gantry view, in which the echo 
view is oriented in the same anatomic alignment as the x-ray 
view and automatically updated by each movement of the 
C-arm gantry; this image is then fused with the X-ray view 
and both images are concordant in size and orientation; 2) 
the « echo » view, which is the standard TOE projection 
showing up on the echo machine; and 3) a free image that 
can be rotated or cropped by the operator at the table site by 
using a sterile mouse pad. This view allows the operator to 
manipulate the real-time images without the need to request 
further TOE projections. There is also a marker feature that 
allows setting markers on anatomical location of interest on 
the echo image that are automatically displayed on the X-Ray 
image. This imaging modality seems useful for the transseptal 
puncture and for sheath and device positioning. This technol-
ogy has the potential to improve the interaction between the 
operator and the imager. Whether this imaging modality may 
increase safety, accuracy, and efficacy of LAA occlusion has 
yet to be demonstrated. Of note, a preliminary study showed 
a significant reduction in radiation dose and fluoroscopy time 
with the use of the EchoNavigator®-system [67].
figure 10: Images Obtained After Rotational Angiography.
A: RAO 20° view. The left atrium (LA) and left atrial appendage 
(LAA) are cut away along the viewing angle (i.e. 20° from frontal), 
the posterior wall of the structures is visible (green). A line is drawn 
at the position where the LAA neck is measured (orange). The bron-
chi (blue) are segmented to verify positioning of the 3D model. The 
Watchman Delivery System (WDS) is positioned in the LAA, with 
the device still in the sheath. Markers on the WDS allow verification 
of adequate LAA length.
B: 3D reconstruction of LAA (left upper corner). The LA is cut 
away; viewing angle is from inside the LA into the LAA ostium. 
Right lower corner shows cross-section at the LAA ostium with 
measurements. Both other images show level where cross-section 
was created (blue lines).
Rotational Angiography
Rotational angiography (3DRA) is an innovative method 
that allows per-procedural reconstruction of tomographic 
slices of a volume of interest in a manner similar to CT, using 
singe plane radiographic equipment [68, 69]. These slices can 
be used to perform measurements in any plane of the 3D vol-
ume, or to make a 3D reconstruction of a structure of interest 
and integrate it with fluoroscopy or other 3D mapping tech-
nologies. In the setting of LAA closure, the technology can 
be leveraged to create near-real time 3D models of the LAA. 
These models provide anatomical guidance by overlaying the 
model on the live 2D fluoroscopy image. Using tools typi-
cally provided by the manufacturer of the X-Ray equipment, 
the 3D model can be appropriately sized and positioned on 
the 2D image, and rotates automatically with the angle of the 
imaging tube to provide the correct visualization (Fig 1). In 
addition, a multiplanar reconstruction can be made through 
any arbitrary angle, such that a planar slice can be created at 
the base of the appendage perpendicular to the long-axis of 
the appendage in that position. This slice can be used to mea-
sure the exact dimensions of the base of the LAA without im-
aging imperfections that may be present with TOE in certain 
anatomies (Fig 2 or Fig 3 or both). Preliminary data suggest 
this workflow may offer more accurate selection of the most 
appropriate LAA occluder size (unpublished data).
CONCLUSIONS
Imaging has a key role in every step of LAA occlusion: 
pre-procedural planning, procedural guidance and post-im-
plantation surveillance. Several imaging modalities are avail-
able and offer complementary information, allowing good 
understanding of the LAA anatomy and its relationship to 
the surrounding structures. Multimodality imaging should 
be used to improve procedural safety and efficacy of LAA 
occlusion.
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